Stay updated on IRCI Gynae Sarcomas, High Grade Uterine Sarcoma Clinical Trial
Sign up to get notified when there's something new on the IRCI Gynae Sarcomas, High Grade Uterine Sarcoma Clinical Trial page.

Latest updates to the IRCI Gynae Sarcomas, High Grade Uterine Sarcoma Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoNo Change Detected
- Check16 days agoChange DetectedSite revision updated from v3.4.3 to v3.5.0. This update changes internal metadata and template version without altering trial information presented on the page.SummaryDifference0.1%

- Check23 days agoNo Change Detected
- Check30 days agoChange DetectedPage revision updated from v3.4.2 to v3.4.3.SummaryDifference0.1%

- Check52 days agoChange DetectedMinor maintenance update; the page revision changed from v3.4.1 to v3.4.2. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check59 days agoChange DetectedThe page revision was updated from v3.4.0 to v3.4.1; no study data or content appears to be altered. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check73 days agoChange DetectedShow glossary toggle added. Metadata updates include 'Last Update Submitted that Met QC Criteria', capitalization adjustments for 'No FEAR Act Data', and a new 'Revision: v3.4.0' tag replacing the previous version (v3.3.4). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check80 days agoChange DetectedPage revision updated from v3.3.3 to v3.3.4. This change does not affect study content, eligibility criteria, locations, or results. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to IRCI Gynae Sarcomas, High Grade Uterine Sarcoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the IRCI Gynae Sarcomas, High Grade Uterine Sarcoma Clinical Trial page.